Market Characteristics/ Description of the Biologics Market
The biologics industry comprises companies manufacturing biological products. Biological products include a wide range of products such as vaccines, somatic cells, tissues, and recombinant therapeutic proteins. Biologics can be composed of sugars, proteins, or nucleic acids or complex combinations of these substances, or may be living entities such as cells and tissues. These products are isolated from natural sources such as human, animal, and microorganisms by biotechnological methods and other cutting-edge technologies. Specifically, most biologic medicines are developed using recombinant DNA (rDNA) technology.
Global Biologics Market Competitive Landscape
The biologics market is highly concentrated, with only a small number of drugs approved from a small number of companies. The top biologics companies in the market include Johnson & Johnson, F. Hoffmann-La Roche Ltd. Bristol-Myers Squibb Company, GlaxoSmithKline Plc., AbbVie Inc., Amgen and Pfizer. Among these companies Johnson & Johnson was estimated to have the highest share in the biologics market.
Biologics Market Size
The global biologics market is expected to reach $319.4 billion by 2021, growing at a CAGR close to 11%. The growth in the market is due to government initiatives for the research and development of biopharmaceutical drugs, increasing healthcare access among developing and underdeveloped nations, and rising mergers and acquisitions in the biologics market.
However, the market is expected to face restraints from several factors such as difficulty in biologics manufacturing, regulatory pricing strategies and rising demand of biosimilars.
Biologics Market Segmentation
The global biologics market is segmented based on the type and geography.
By type the biologics market is segmented into monoclonal antibodies, therapeutic proteins and vaccines.
Monoclonal antibodies are derived by cell division from a single ancestral cell. These antibodies recognize and bind to antigens in order to discriminate between specific epitopes which provide protection against disease organisms.
The report further shows the segmentation of monoclonal antibodies by source and by therapeutic area.
Therapeutic proteins are proteins that are engineered in the laboratory for pharmaceutical use. These proteins include cytokines, peptide hormones and enzymes.
The report further describes the segmentation of therapeutic proteins by type and by therapeutic area.
Vaccines are biological preparations that provide immunity from a disease. Vaccines can be administered orally, through injections or by aerosol. These are used for prophylactic (preventive) or therapeutic purposes.
Vaccines are further segmented by end user and by therapeutic area.
By geography the global biologics market is segmented into five regions- North America, South America, Asia Pacific, Western Europe, Eastern Europe and Middle East and Africa.
Trends in the Biologics Market
Major trends witnessed in the biologics market over the historic period include increasing demand for biologics in the treatment of complex diseases, rising development of next generation biologics and revised FDA regulations facilitating biologics drug development.
Potential Opportunities in the Biologics Market
With rising ageing population, growing investments and healthcare access among emerging economies, the demand and scope for the biologics market is expected to increase in the forecast period.